A Randomized Controlled Trial of OC-Go for Childhood Obsessive–Compulsive Disorder: Augmenting Homework Compliance in Exposure With Response Prevention Treatment
Behavior Therapy · 2024
DOI: 10.1016/j.beth.2023.07.005 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Behavior Therapy, 2024. Verfasst von Peter W Tuerk und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Virginia. Electronic address: pwt3g@virginia.edu. Hauptthemen laut MEDLINE: Cognitive Behavioral Therapy, Obsessive-Compulsive Disorder. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: NIMH NIH HHS, National Institutes of Health, National Institute of Mental Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Virginia. Electronic address: pwt3g@virginia.edu.
- Johns Hopkins University School of Medicine and University of California, Los Angeles.
- University of California, Los Angeles.
Förderung
- NIMH NIH HHS
- National Institutes of Health
- National Institute of Mental Health
Zitieren
APA
Tuerk, P. W., McGuire, J. F., & Piacentini, J. (2024). A Randomized Controlled Trial of OC-Go for Childhood Obsessive–Compulsive Disorder: Augmenting Homework Compliance in Exposure With Response Prevention Treatment. Behavior Therapy. https://doi.org/10.1016/j.beth.2023.07.005
Vancouver
Tuerk PW, McGuire JF, Piacentini J. A Randomized Controlled Trial of OC-Go for Childhood Obsessive–Compulsive Disorder: Augmenting Homework Compliance in Exposure With Response Prevention Treatment. Behavior Therapy. 2024. doi:10.1016/j.beth.2023.07.005
BibTeX
@article{Tuerk2024,
author = {Tuerk, Peter W and McGuire, Joseph F and Piacentini, John},
title = {A Randomized Controlled Trial of OC-Go for Childhood Obsessive–Compulsive Disorder: Augmenting Homework Compliance in Exposure With Response Prevention Treatment},
journal = {Behavior Therapy},
year = {2024},
doi = {10.1016/j.beth.2023.07.005}
}
EUVIMED